Cargando…
Safety Profile of Oxaliplatin in 3,687 Patients With Cancer in China: A Post-Marketing Surveillance Study
BACKGROUND: Oxaliplatin (OXA), a third-generation platinum derivative, has become one of the main chemotherapeutic drugs for colorectal cancer and other cancers, but reports of adverse reactions are also increasing with the extensive application of OXA. In this study, post-marketing surveillance was...
Autores principales: | Yu, Zaoqin, Huang, Rui, Zhao, Li, Wang, Ximin, Shangguan, Xiaofang, Li, Wei, Li, Min, Yin, Xianguo, Zhang, Chengliang, Liu, Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567037/ https://www.ncbi.nlm.nih.gov/pubmed/34745993 http://dx.doi.org/10.3389/fonc.2021.757196 |
Ejemplares similares
-
Knowledge, Practices, and Perceived Barriers in Cancer Pain Management at Oncology Units: A Cross-Sectional Survey of Medical Staff in China
por: Yu, Zaoqin, et al.
Publicado: (2022) -
Post-Marketing Surveillance of a generic Oxaliplatin (Alvoxal(Ⓡ)) in Iranian Patients with Cancer
por: Shahi, Farhad, et al.
Publicado: (2021) -
Safety of Tumor Treating Fields (TTFields) therapy in pediatric patients with malignant brain tumors: Post-marketing surveillance data
por: Goldman, Stewart, et al.
Publicado: (2022) -
Upregulation of miR-3195, miR-3687 and miR-4417 is associated with castration-resistant prostate cancer
por: Rönnau, C. G. H., et al.
Publicado: (2021) -
Feasibility and Safety of Perioperative Chemotherapy With Fluorouracil Plus Leucovorin, Oxaliplatin, and Docetaxel for Locally Advanced Gastric Cancer Patients in China
por: Sah, Birendra Kumar, et al.
Publicado: (2021)